All Type of News
Foreign drugmakers under fire over low wholesaler margin policy
Tension has been escalating as domestic pharmaceutical wholesalers are calling for multinational pharmaceutical firms to guarantee the proper wholesaler margin, while vowing to work out proper measures.
Under the c...
Mvix 50 mg is available on market
SK Chemicals announced on March 2 that it has launched the once daily use Mvix 50 mg, an oral medication taken once per day to treat erectile dysfunction (ED), with half price of Mvix 100 mg.
When Mvix for once dai...
Baxter launches FloSeal For surgical bleeding
Baxter Internation Inc. said it has launched FlosSeal, an effective hemostat that stops bleeding in 2 minutes or less (median time to hemostasis).
The product will be supplied through NHS in Korea.
FloSeal is a ...
C.A Pharm eyes US market with Placentra
C.A Pharm, a local alternative medicine producer, plans to make inroad to the U.S. market with its flagship product Placentra, an OTC product for removal of stretch mark in pregnant woman.
Placentra is based on a s...
Ur picked to head KPMA
The Korea Pharmaceutical Manufacturers Association said February 27 that Ur Choon-sun, CEO of Ahngook Pharm, was re-elected as its 19th chairman during the general meeting.
An advisory committee comprised of eight ...
Korea’s pharmaceutical exports top $1.6 billion
The nation’s drug exports reached $1.61 billion last year, soaring 10.2 percent, a report showed on February 27.
Exports growth was led by increased sales of finished pharmaceutical products ($685 million) and raw ...
Training is key to revitalizing pharmaceutical sector
Domestic pharmaceutical firms’ more attention should be given to training to boost sales measures amid the economic downturn, according to a local human resource development institute.
The Hyundai Economic Research...
Yuhan targets W1.7 trillion by 2014
Yuhan Corporation aims to achieve 1.7 trillion won in annual sales by 2014 with the intention of emerging as one of the best-performing pharmaceutical companies in the world, a company executive said recently.
“We ...
Dream Pharma, ICURE to cooperate
Cooperation between Dream Pharma and ICURE and is picking up, with efforts being made to step up exchanges in the are ICURE as of development and application of patch technology and joint research on promising patch c...
Drugmakers skeptical about new bio-related funds
Pharmaceutical circles are skeptical about the government’s plan to create the bio-pharmaceutical funds of 250 billion won.
The Ministry of Knowledge Economy announces its long-term plan to nurture the nation’s bio...
